Tag: pediatric-onset multiple sclerosis (POMS)

23-NEU-3813859-drug-formulations-650×450
April 28, 2023/Neurosciences/Pediatrics

Switching Disease-Modifying Therapies in Pediatric Multiple Sclerosis: Insights From Real-World Data

Relapse rates were lower with oral or infusion therapy after initial injectable DMT

21-NEU-2437861-pediatric-MS-650×450
November 16, 2021/Neurosciences/Podcast

Advancements in the Care of Pediatric Neuroinflammatory Disorders (Podcast)

Early intervention, improved diagnostics and new therapies yield better outcomes

18-NEU-733-Pediatric-MS-650×450

Pediatric-Onset MS: Study Confirms Some Features, Flags Others as Research Priorities

Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad